JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4926
The Honest Company
HNST
$546M
| $168K | ﹤0.01% |
93,008
+8,905
| +11% | +$24.3K |
2021 Q2
7 quarters
|
|
|
NARI
4927
CALL
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $167K | ﹤0.01% |
+2,700
| New | +$162K |
2023 Q1
0 quarters
|
|
4928
ORIX
IX
$40.1B
| $167K | ﹤0.01% |
10,135
-1,140
| -10% | -$19.5K |
2013 Q2
39 quarters
|
|
4929
Ceco Environmental
CECO
$4.42B
| $166K | ﹤0.01% |
11,842
-19,973
| -63% | -$282K |
2016 Q4
25 quarters
|
|
4930
CALL
American Airlines Group
AAL
$8.63B
| $165K | ﹤0.01% |
11,200
-141,300
| -93% | -$2.2M |
2022 Q4
1 quarter
|
|
4931
PUT
Wingstop
WING
$3.07B
| $165K | ﹤0.01% |
+900
| New | +$148K |
2023 Q1
0 quarters
|
|
|
BOXD
4932
DELISTED
Boxed, Inc.
BOXD
| $165K | ﹤0.01% |
863,303
+6,096
| +0.7% | +$2.74K |
2021 Q4
5 quarters
|
|
4933
Concrete Pumping Holdings
BBCP
$501M
| $164K | ﹤0.01% |
24,020
+3,705
| +18% | +$26.9K |
2019 Q1
16 quarters
|
|
4934
Brown-Forman Class A
BF.A
$12.4B
| $164K | ﹤0.01% |
2,525
+375
| +17% | +$24.4K |
2015 Q4
29 quarters
|
|
4935
Fidelity D&D Bancorp
FDBC
$321M
| $164K | ﹤0.01% |
3,601
+3,567
| +10,491% | +$170K |
2018 Q2
19 quarters
|
|
4936
MainStreet Bancshares
MNSB
$178M
| $164K | ﹤0.01% |
7,011
+7,000
| +63,636% | +$192K |
2019 Q2
15 quarters
|
|
|
CTLT
4937
PUT
DELISTED
CATALENT, INC.
CTLT
| $164K | ﹤0.01% |
+2,500
| New | +$154K |
2023 Q1
0 quarters
|
|
|
HT
4938
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $164K | ﹤0.01% |
24,461
-2,831
| -10% | -$23K |
2013 Q2
39 quarters
|
|
4939
Algoma Steel
ASTL
$467M
| $163K | ﹤0.01% |
+20,170
| New | +$154K |
2023 Q1
0 quarters
|
|
4940
CleanSpark
CLSK
$3.16B
| $163K | ﹤0.01% |
58,826
+30,004
| +104% | +$82.3K |
2021 Q1
8 quarters
|
|
4941
PUT
Fidelity National Information Services
FIS
$17.4B
| $163K | ﹤0.01% |
+3,000
| New | +$195K |
2023 Q1
0 quarters
|
|
4942
Nektar Therapeutics
NKTR
$1.37B
| $163K | ﹤0.01% |
15,499
+2,765
| +22% | +$83.7K |
2013 Q2
39 quarters
|
|
|
SOND
4943
DELISTED
Sonder
SOND
| $163K | ﹤0.01% |
10,764
+2,288
| +27% | +$53.1K |
2021 Q4
5 quarters
|
|
|
ISEE
4944
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $163K | ﹤0.01% |
+6,700
| New | +$147K |
2023 Q1
0 quarters
|
|
|
EQIN
4945
Columbia U.S. Equity Income ETF
EQIN
$306M
| $163K | ﹤0.01% |
4,318
+238
| +6% | +$9.04K |
2022 Q4
1 quarter
|
|
4946
5E Advanced Materials
FEAM
$169M
| $162K | ﹤0.01% |
1,306
+327
| +33% | +$61.1K |
2022 Q2
3 quarters
|
|
|
CS
4947
DELISTED
Credit Suisse Group
CS
| $162K | ﹤0.01% |
182,501
-307,713
| -63% | -$858K |
2013 Q2
39 quarters
|
|
4948
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.34B
| $161K | ﹤0.01% |
+4,986
| New | +$158K |
2023 Q1
0 quarters
|
|
4949
iShares Agency Bond ETF
AGZ
$633M
| $161K | ﹤0.01% |
1,491
-6,848
| -82% | -$736K |
2020 Q1
12 quarters
|
|
4950
PUT
Crown Castle
CCI
$29.1B
| $161K | ﹤0.01% |
+1,200
| New | +$166K |
2023 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.